Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma

医学 肝细胞癌 切除术 肝切除术 癌 普通外科 放射科 外科 内科学
作者
Alessandro Vitale,Pierluigi Romano,Umberto Cillo,Writing Group for the HE.RC.O.LE.S Collaborative Group,Writing Group for the ITA.LI.CA Collaborative Group,HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups,Marco Busti,Giulia Nezi,Riccardo De Carlis,Francesca Ratti,Flavio Milana,Matteo Donadon,Laura Marinelli,Francesco Razionale,Francesca Carissimi,Mauro Alessandro Scotti,Cristina Ciulli,Valerio De Peppo,Nadia Russolillo,Mauro Giuffrida
出处
期刊:JAMA Surgery [American Medical Association]
卷期号:159 (8): 881-881 被引量:56
标识
DOI:10.1001/jamasurg.2024.1184
摘要

Importance: The 2022 Barcelona Clinic Liver Cancer algorithm currently discourages liver resection (LR) for patients with multinodular hepatocellular carcinoma (HCC) presenting with 2 or 3 nodules that are each 3 cm or smaller. Objective: To compare the efficacy of liver resection (LR), percutaneous radiofrequency ablation (PRFA), and transarterial chemoembolization (TACE) in patients with multinodular HCC. Design, Setting, and Participants: This cohort study is a retrospective analysis conducted using data from the HE.RC.O.LE.S register (n = 5331) for LR patients and the ITA.LI.CA database (n = 7056) for PRFA and TACE patients. A matching-adjusted indirect comparison (MAIC) method was applied to balance data and potential confounding factors between the 3 groups. Included were patients from multiple centers from 2008 to 2020; data were analyzed from January to December 2023. Interventions: LR, PRFA, or TACE. Main Outcomes and Measures: Survival rates at 1, 3, and 5 years were calculated. Cox MAIC-weighted multivariable analysis and competing risk analysis were used to assess outcomes. Results: A total of 720 patients with early multinodular HCC were included, 543 males (75.4%), 177 females (24.6%), and 350 individuals older than 70 years (48.6%). There were 296 patients in the LR group, 240 who underwent PRFA, and 184 who underwent TACE. After MAIC, LR exhibited 1-, 3-, and 5-year survival rates of 89.11%, 70.98%, and 56.44%, respectively. PRFA showed rates of 94.01%, 65.20%, and 39.93%, while TACE displayed rates of 90.88%, 48.95%, and 29.24%. Multivariable Cox survival analysis in the weighted population showed a survival benefit over alternative treatments (PRFA vs LR: hazard ratio [HR], 1.41; 95% CI, 1.07-1.86; P = .01; TACE vs LR: HR, 1.86; 95% CI, 1.29-2.68; P = .001). Competing risk analysis confirmed a lower risk of cancer-related death in LR compared with PRFA and TACE. Conclusions and Relevance: For patients with early multinodular HCC who are ineligible for transplant, LR should be prioritized as the primary therapeutic option, followed by PRFA and TACE when LR is not feasible. These findings provide valuable insights for clinical decision-making in this patient population.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
今后的应助被Moon采纳,获得10
刚刚
高兴的夜天完成签到,获得积分10
1秒前
CAOHOU的应助被六六采纳,获得10
1秒前
您吃了吗完成签到,获得积分10
1秒前
2秒前
小刘恨香菜完成签到,获得积分10
3秒前
3秒前
Ayan完成签到,获得积分10
3秒前
ZJ发布了新的文献求助10
3秒前
MM完成签到,获得积分10
3秒前
星星海给星星海的求助进行了留言
3秒前
俭朴苑博的应助被Pan采纳,获得10
4秒前
归途发布了新的文献求助10
4秒前
5秒前
慕豁发布了新的文献求助20
5秒前
5秒前
5秒前
刘奇发布了新的文献求助10
5秒前
王智发布了新的文献求助10
5秒前
经竺的应助被cola采纳,获得10
5秒前
slk发布了新的文献求助10
5秒前
在水一方的应助被tianzhen采纳,获得10
5秒前
Azure完成签到 ,获得积分10
6秒前
shuo关注了科研通微信公众号
6秒前
王多余完成签到,获得积分10
6秒前
6秒前
1233完成签到,获得积分20
7秒前
叶子发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
muyu完成签到,获得积分10
8秒前
学学球完成签到,获得积分10
9秒前
Christoph_Lee发布了新的文献求助10
9秒前
荼蘼发布了新的文献求助10
9秒前
10秒前
我是老大的应助被Wang采纳,获得10
10秒前
鹤轸完成签到 ,获得积分10
10秒前
10秒前
风中远山完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180807
求助须知:如何正确求助?哪些是违规求助? 9570895
关于积分的说明 21815089
捐赠科研通 7777155
什么是DOI,文献DOI怎么找? 3433347
关于科研通互助平台的介绍 2557613
邀请新用户注册赠送积分活动 2479317